IFNG and gastrointestinal stromal tumor: We also evaluated specifically immune-related gene signatures previously analyzed in GIST [10] and first described as predictors of immunotherapy response [22,23], these are the expanded IFN-γ-induced immune signature (EIIS) and the T-cell-inflamed signature (TIS).